These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 18782572)

  • 1. Cordycepin inhibits vascular smooth muscle cell proliferation.
    Chang W; Lim S; Song H; Song BW; Kim HJ; Cha MJ; Sung JM; Kim TW; Hwang KC
    Eur J Pharmacol; 2008 Nov; 597(1-3):64-9. PubMed ID: 18782572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tauroursodeoxycholate (TUDCA) inhibits neointimal hyperplasia by suppression of ERK via PKCα-mediated MKP-1 induction.
    Kim SY; Kwon YW; Jung IL; Sung JH; Park SG
    Cardiovasc Res; 2011 Nov; 92(2):307-16. PubMed ID: 21840882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New mechanism of rosiglitazone to reduce neointimal hyperplasia: activation of glycogen synthase kinase-3beta followed by inhibition of MMP-9.
    Lee CS; Kwon YW; Yang HM; Kim SH; Kim TY; Hur J; Park KW; Cho HJ; Kang HJ; Park YB; Kim HS
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):472-9. PubMed ID: 19201691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Efficacy of Systemic Doxycycline Administration as an Inhibitor of Intimal Hyperplasia after Balloon Angioplasty Arterial Injury.
    Mountain DJH; Kirkpatrick SS; Arnold JD; Buckley MR; McNally MM; Stevens SL; Freeman MB; Grandas OH
    Ann Vasc Surg; 2019 May; 57():201-209. PubMed ID: 30684618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-Methoxyphenyl (E)-3-(Furan-3-yl) Acrylate Inhibits Vascular Smooth Muscle Cell Proliferation.
    Han S; Son M; Lee Y; Cheon SH; Kim SW
    J Cardiovasc Pharmacol; 2020 Jul; 76(1):106-111. PubMed ID: 32644321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nelumbo nucifera leaf extract inhibits neointimal hyperplasia through modulation of smooth muscle cell proliferation and migration.
    Karki R; Jeon ER; Kim DW
    Nutrition; 2013 Jan; 29(1):268-75. PubMed ID: 22959632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADAMTS-7 mediates vascular smooth muscle cell migration and neointima formation in balloon-injured rat arteries.
    Wang L; Zheng J; Bai X; Liu B; Liu CJ; Xu Q; Zhu Y; Wang N; Kong W; Wang X
    Circ Res; 2009 Mar; 104(5):688-98. PubMed ID: 19168437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of neointimal hyperplasia in the rat carotid artery injury model by a HMGB1 inhibitor.
    Chen J; Zhang J; Xu L; Xu C; Chen S; Yang J; Jiang H
    Atherosclerosis; 2012 Oct; 224(2):332-9. PubMed ID: 22857898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dipeptidyl peptidase-4 inhibition by gemigliptin prevents abnormal vascular remodeling via NF-E2-related factor 2 activation.
    Choi SH; Park S; Oh CJ; Leem J; Park KG; Lee IK
    Vascul Pharmacol; 2015 Oct; 73():11-9. PubMed ID: 26187356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gliotoxin inhibits neointimal hyperplasia after vascular injury in rats.
    Pozo M; Izquierdo MC; de Nicolás R; Egido J; Ortiz A; González-Cabrero J
    J Vasc Res; 2009; 46(4):278-89. PubMed ID: 19033690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine A₂B receptor agonism inhibits neointimal lesion development after arterial injury in apolipoprotein E-deficient mice.
    Bot I; de Vries H; Korporaal SJ; Foks AC; Bot M; van Veldhoven J; Ter Borg MN; van Santbrink PJ; van Berkel TJ; Kuiper J; Ijzerman AP
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2197-205. PubMed ID: 22743060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linarin Ameliorates Restenosis After Vascular Injury in Type 2 Diabetes Mellitus via Regulating ADAM10-Mediated Notch Signaling Pathway.
    Jiang A; Liu L; Wang J; Liu Y; Deng S; Jiang T
    Cardiovasc Toxicol; 2024 Jun; 24(6):587-597. PubMed ID: 38691303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of NAD(P)H:quinone oxidoreductase 1 prevents arterial restenosis by suppressing vascular smooth muscle cell proliferation.
    Kim SY; Jeoung NH; Oh CJ; Choi YK; Lee HJ; Kim HJ; Kim JY; Hwang JH; Tadi S; Yim YH; Lee KU; Park KG; Huh S; Min KN; Jeong KH; Park MG; Kwak TH; Kweon GR; Inukai K; Shong M; Lee IK
    Circ Res; 2009 Apr; 104(7):842-50. PubMed ID: 19229058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease-activated receptor-1 antagonist F 16618 reduces arterial restenosis by down-regulation of tumor necrosis factor α and matrix metalloproteinase 7 expression, migration, and proliferation of vascular smooth muscle cells.
    Chieng-Yane P; Bocquet A; Létienne R; Bourbon T; Sablayrolles S; Perez M; Hatem SN; Lompré AM; Le Grand B; David-Dufilho M
    J Pharmacol Exp Ther; 2011 Mar; 336(3):643-51. PubMed ID: 21139058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversion-inducing-cysteine-rich protein with Kazal motif is involved in intimal hyperplasia in carotid arteries: a new insight in the prevention of restenosis after vascular angioplasty.
    Liu J; Chi D; Lu H; Zhang T; Yamakawa T
    Ann Vasc Surg; 2015 Aug; 29(6):1293-9. PubMed ID: 26004948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fludarabine prevents smooth muscle proliferation in vitro and neointimal hyperplasia in vivo through specific inhibition of STAT-1 activation.
    Torella D; Curcio A; Gasparri C; Galuppo V; De Serio D; Surace FC; Cavaliere AL; Leone A; Coppola C; Ellison GM; Indolfi C
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2935-43. PubMed ID: 17293493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis.
    Hytönen J; Leppänen O; Braesen JH; Schunck WH; Mueller D; Jung F; Mrowietz C; Jastroch M; von Bergwelt-Baildon M; Kappert K; Heuser A; Drenckhahn JD; Pieske B; Thierfelder L; Ylä-Herttuala S; Blaschke F
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1534-48. PubMed ID: 27283742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTP synthase 1, a smooth muscle-sensitive therapeutic target for effective vascular repair.
    Tang R; Cui XB; Wang JN; Chen SY
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2336-44. PubMed ID: 24008161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implication of adenylyl cyclase 8 in pathological smooth muscle cell migration occurring in rat and human vascular remodelling.
    Gueguen M; Keuylian Z; Mateo V; Mougenot N; Lompré AM; Michel JB; Meilhac O; Lipskaia L; Limon I
    J Pathol; 2010 Jul; 221(3):331-42. PubMed ID: 20527026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hormone replacement therapy in matrix metalloproteinase expression and intimal hyperplasia development after vascular injury.
    Mountain DJ; Freeman MB; Kirkpatrick SS; Cook RB; Chalk JE; Stevens SL; Goldman MH; Grandas OH
    Ann Vasc Surg; 2013 Apr; 27(3):337-45. PubMed ID: 23088810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.